Immix Biopharma Stock Drops Significantly On News of Chief Medical Officer Arrest - IMMX Investors Encouraged to Contact Kehoe Law Firm, P.C. Regarding Potential Securities Fraud Claims Ready to Announce with Confidence?
Philadelphia, Pennsylvania--(Newsfile Corp. - July 20, 2026) - Kehoe Law Firm, P.C. is investigating potential securities fraud claims on behalf of investors of Immix Biopharma, Inc. ("Immix Biopharma") (NASDAQ: IMMX).
On July 20, 2026, Investing.com reported that "Immix Biopharma Inc . . . shares fell 13% . . . after STAT News reported that one of Rhode Island's most-wanted fugitives appears to have been working as an executive at the company."
Additionally, "[a]ccording to the report, Ronald Fischer, 70, was arrested last week by federal and Rhode Island authorities after they tracked and boarded a 56-foot sailboat off the coast of New Jersey. Fischer, a former anesthesiologist, disappeared in 2005 while on trial for first-degree sexual assault."
On this news, shares of Immix Biopharma dropped more than 13% during intraday trading on July 20, 2026.
Immix Biopharma investors with financial losses are encouraged to complete Kehoe Law Firm's Stockholder Information Request Form or contact Michael Yarnoff, Esq., (215) 792-6676, Ext. 804, myarnoff@kehoelawfirm.com, info@kehoelawfirm.com, for additional information and a free, no-obligation evaluation of potential legal claims.
ABOUT KEHOE LAW FIRM, P.C.
Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action firm dedicated to protecting investors and consumers from fraud and misconduct. Our attorneys have served as Lead or Co-Lead Counsel in major securities cases, recovering over $10 billion for institutional and individual investors.
Our firm litigates securities fraud, fiduciary breaches, unfair mergers and acquisitions, and antitrust violations, while also representing whistleblowers and advocating for victims of data breaches, consumer fraud, vehicle and product defects, employment law violations, retirement plan mismanagement, and other corporate and business misconduct. With a results-driven approach, we pursue justice and substantial recoveries for those we represent.
This press release may constitute attorney advertising.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/305788
Source: Kehoe Law Firm, P.C.
Analyst, journalist, or company stakeholder? Sign up to receive news releases by email for Kehoe Law Firm, P.C. or all companies in the Banking / Financial Services industry.
Immix Biopharma Stock Drops Significantly On News of Chief Medical Officer Arrest - IMMX Investors Encouraged to Contact Kehoe Law Firm, P.C. Regarding Potential Securities Fraud Claims
2026-07-20 12:13 PM EDT
Pentair plc Investors Encouraged to Contact Kehoe Law Firm, P.C. Regarding Potential Securities Fraud Claims - (PNR)
2026-07-16 9:35 AM EDT
HUB GROUP - Kehoe Law Firm, P.C. Investigating Potential Securities Fraud Claims on Behalf of Hub Group Investors (HUBG)
2026-05-12 10:49 AM EDT
Feb 27, 2026
An advisor enters a ticker into a brokerage dashboard. A retail investor searches a fund on Yahoo Finance. An institutional analyst checks a terminal feed before a client meeting. In that moment, they are not simply looking for a price quote. They are looking for context. And increasingly, what they see is silence. The global ETF market now exceeds $20 trillion in assets under management. At the end of November 2025, the industry included more than 15,600 products and over 30,000 ...
Litigation and Regulation
Banking / Financial Services